These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18522242)

  • 21. In vitro and in vivo staining characteristics of small, fluorescent, Abeta42-binding D-enantiomeric peptides in transgenic AD mouse models.
    van Groen T; Kadish I; Wiesehan K; Funke SA; Willbold D
    ChemMedChem; 2009 Feb; 4(2):276-82. PubMed ID: 19072935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
    Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
    J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice.
    Oksman M; Iivonen H; Hogyes E; Amtul Z; Penke B; Leenders I; Broersen L; Lütjohann D; Hartmann T; Tanila H
    Neurobiol Dis; 2006 Sep; 23(3):563-72. PubMed ID: 16765602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced susceptibility of S-100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human beta-amyloid.
    Craft JM; Watterson DM; Marks A; Van Eldik LJ
    Glia; 2005 Aug; 51(3):209-16. PubMed ID: 15810011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo labelling of hippocampal beta-amyloid in triple-transgenic mice with a fluorescent acetylcholinesterase inhibitor released from nanoparticles.
    Härtig W; Kacza J; Paulke BR; Grosche J; Bauer U; Hoffmann A; Elsinghorst PW; Gütschow M
    Eur J Neurosci; 2010 Jan; 31(1):99-109. PubMed ID: 20092557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice.
    Lord A; Kalimo H; Eckman C; Zhang XQ; Lannfelt L; Nilsson LN
    Neurobiol Aging; 2006 Jan; 27(1):67-77. PubMed ID: 16298242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One-year longitudinal evaluation of sensorimotor functions in APP751SL transgenic mice.
    Le Cudennec C; Faure A; Ly M; Delatour B
    Genes Brain Behav; 2008 Feb; 7 Suppl 1():83-91. PubMed ID: 18184372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice.
    Thal DR; Larionov S; Abramowski D; Wiederhold KH; Van Dooren T; Yamaguchi H; Haass C; Van Leuven F; Staufenbiel M; Capetillo-Zarate E
    Neurobiol Aging; 2007 Aug; 28(8):1221-30. PubMed ID: 16815595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice.
    Knobloch M; Konietzko U; Krebs DC; Nitsch RM
    Neurobiol Aging; 2007 Sep; 28(9):1297-306. PubMed ID: 16876915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transgenic potato expressing Abeta reduce Abeta burden in Alzheimer's disease mouse model.
    Youm JW; Kim H; Han JH; Jang CH; Ha HJ; Mook-Jung I; Jeon JH; Choi CY; Kim YH; Kim HS; Joung H
    FEBS Lett; 2005 Dec; 579(30):6737-44. PubMed ID: 16310782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity.
    Imbimbo BP; Del Giudice E; Colavito D; D'Arrigo A; Dalle Carbonare M; Villetti G; Facchinetti F; Volta R; Pietrini V; Baroc MF; Serneels L; De Strooper B; Leon A
    J Pharmacol Exp Ther; 2007 Dec; 323(3):822-30. PubMed ID: 17895400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective vulnerability of different types of commissural neurons for amyloid beta-protein-induced neurodegeneration in APP23 mice correlates with dendritic tree morphology.
    Capetillo-Zarate E; Staufenbiel M; Abramowski D; Haass C; Escher A; Stadelmann C; Yamaguchi H; Wiestler OD; Thal DR
    Brain; 2006 Nov; 129(Pt 11):2992-3005. PubMed ID: 16844716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice.
    Philipson O; Hammarström P; Nilsson KP; Portelius E; Olofsson T; Ingelsson M; Hyman BT; Blennow K; Lannfelt L; Kalimo H; Nilsson LN
    Neurobiol Aging; 2009 Sep; 30(9):1393-405. PubMed ID: 18192084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer beta-amyloid peptides: structures of amyloid fibrils and alternate aggregation products.
    Gorman PM; Chakrabartty A
    Biopolymers; 2001; 60(5):381-94. PubMed ID: 12115148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The bad seed in Alzheimer's disease.
    Fryer JD; Holtzman DM
    Neuron; 2005 Jul; 47(2):167-8. PubMed ID: 16039556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease?
    Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD
    J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw).
    Crawford FC; Wood M; Ferguson S; Mathura VS; Faza B; Wilson S; Fan T; O'Steen B; Ait-Ghezala G; Hayes R; Mullan MJ
    Brain Res; 2007 Dec; 1185():45-58. PubMed ID: 17961517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.
    Garcia-Alloza M; Robbins EM; Zhang-Nunes SX; Purcell SM; Betensky RA; Raju S; Prada C; Greenberg SM; Bacskai BJ; Frosch MP
    Neurobiol Dis; 2006 Dec; 24(3):516-24. PubMed ID: 17029828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques.
    Kumar-Singh S
    Genes Brain Behav; 2008 Feb; 7 Suppl 1():67-82. PubMed ID: 18184371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.